These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 15569000)

  • 1. Relationship of serum osteoprotegerin levels with coronary artery disease severity, left ventricular hypertrophy and C-reactive protein.
    Rhee EJ; Lee WY; Kim SY; Kim BJ; Sung KC; Kim BS; Kang JH; Oh KW; Oh ES; Baek KH; Kang MI; Woo HY; Park HS; Kim SW; Lee MH; Park JR
    Clin Sci (Lond); 2005 Mar; 108(3):237-43. PubMed ID: 15569000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relationship between four single nucleotide polymorphisms in the promoter region of the osteoprotegerin gene and aortic calcification or coronary artery disease in Koreans.
    Rhee EJ; Oh KW; Jung CH; Lee WY; Oh ES; Yun EJ; Baek KH; Kang MI; Kim SW
    Clin Endocrinol (Oxf); 2006 Jun; 64(6):689-97. PubMed ID: 16712673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relationship between plasma osteoprotegerin levels and coronary artery calcification in uncomplicated type 2 diabetic subjects.
    Anand DV; Lahiri A; Lim E; Hopkins D; Corder R
    J Am Coll Cardiol; 2006 May; 47(9):1850-7. PubMed ID: 16682312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum osteoprotegerin levels are associated with the presence and severity of coronary artery disease.
    Jono S; Ikari Y; Shioi A; Mori K; Miki T; Hara K; Nishizawa Y
    Circulation; 2002 Sep; 106(10):1192-4. PubMed ID: 12208791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased osteoprotegerin serum levels in men with coronary artery disease.
    Schoppet M; Sattler AM; Schaefer JR; Herzum M; Maisch B; Hofbauer LC
    J Clin Endocrinol Metab; 2003 Mar; 88(3):1024-8. PubMed ID: 12629080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating osteoprotegerin is correlated with lipid profile, insulin sensitivity, adiponectin and sex steroids in an ageing male population.
    Gannagé-Yared MH; Fares F; Semaan M; Khalife S; Jambart S
    Clin Endocrinol (Oxf); 2006 Jun; 64(6):652-8. PubMed ID: 16712667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum osteoprotegerin levels and the extent of vascular calcification in haemodialysis patients.
    Nitta K; Akiba T; Uchida K; Otsubo S; Takei T; Yumura W; Kabaya T; Nihei H
    Nephrol Dial Transplant; 2004 Jul; 19(7):1886-9. PubMed ID: 15128884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum levels of osteoprotegerin and RANKL in patients with ST elevation acute myocardial infarction.
    Crisafulli A; Micari A; Altavilla D; Saporito F; Sardella A; Passaniti M; Raffa S; D'anneo G; Lucà F; Mioni C; Arrigo F; Squadrito F
    Clin Sci (Lond); 2005 Oct; 109(4):389-95. PubMed ID: 15926884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The progression of vascular calcification and serum osteoprotegerin levels in patients on long-term hemodialysis.
    Nitta K; Akiba T; Uchida K; Kawashima A; Yumura W; Kabaya T; Nihei H
    Am J Kidney Dis; 2003 Aug; 42(2):303-9. PubMed ID: 12900812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum osteoprotegerin and its ligand in Paget's disease of bone: relationship to disease activity and effect of treatment with bisphosphonates.
    Alvarez L; Peris P; Guañabens N; Vidal S; Ros I; Pons F; Filella X; Monegal A; Muñoz-Gomez J; Ballesta AM
    Arthritis Rheum; 2003 Mar; 48(3):824-8. PubMed ID: 12632438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating osteoprotegerin levels are associated with age, waist-to-hip ratio, serum total cholesterol, and low-density lipoprotein cholesterol levels in healthy Korean women.
    Oh ES; Rhee EJ; Oh KW; Lee WY; Baek KH; Yoon KH; Kang MI; Yun EJ; Park CY; Choi MG; Yoo HJ; Park SW
    Metabolism; 2005 Jan; 54(1):49-54. PubMed ID: 15562379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive Value of Osteoprotegerin for Detecting Coronary Artery Calcification in Type 2 Diabetes Mellitus Patients in Correlation with Extent of Calcification Detected by Multidetector Computed Tomography.
    Ahmed S; Sobh R
    Endocr Metab Immune Disord Drug Targets; 2019; 19(6):845-851. PubMed ID: 30747085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum levels of calcification inhibition proteins and coronary artery calcium score: comparison between transplantation and dialysis.
    Mazzaferro S; Pasquali M; Pugliese F; Barresi G; Carbone I; Francone M; Sardella D; Taggi F
    Am J Nephrol; 2007; 27(1):75-83. PubMed ID: 17259697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can osteoprotegerin be used to identify the presence and severity of coronary artery disease in different clinical settings?
    Hosbond SE; Diederichsen AC; Saaby L; Rasmussen LM; Lambrechtsen J; Munkholm H; Sand NP; Gerke O; Poulsen TS; Mickley H
    Atherosclerosis; 2014 Oct; 236(2):230-6. PubMed ID: 25104079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of osteoprotegerin and sRANKL concentrations in serum and bone marrow of multiple myeloma patients.
    Kraj M; Owczarska K; Sokołowska U; Centkowski P; Pogłód R; Kruk B
    Arch Immunol Ther Exp (Warsz); 2005; 53(5):454-64. PubMed ID: 16314829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of serum osteoprotegerin levels in patients with bladder carcinoma.
    Mizutani Y; Matsubara H; Yamamoto K; Nan Li Y; Mikami K; Okihara K; Kawauchi A; Bonavida B; Miki T
    Cancer; 2004 Oct; 101(8):1794-802. PubMed ID: 15386310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased serum osteoprotegerin values in long-lived subjects: different effects of inflammation and bone metabolism.
    Mazziotti G; Amato G; Sorvillo F; Piscopo M; Rizzo MR; Lalli E; Iride L; Cioffi M; Molinari AM; Paolisso G; Carella C
    Eur J Endocrinol; 2006 Mar; 154(3):373-7. PubMed ID: 16498049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum osteoprotegerin levels are associated with inflammation and pulse wave velocity.
    Kim SM; Lee J; Ryu OH; Lee KW; Kim HY; Seo JA; Kim SG; Kim NH; Baik SH; Choi DS; Choi KM
    Clin Endocrinol (Oxf); 2005 Nov; 63(5):594-8. PubMed ID: 16268814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Using the ratio of serum osteoprotegerin ligand to osteoprotegerin to evaluate renal osteodystrophy in dialysis patients.
    Grzegorzewska AE; Mlot M
    Adv Perit Dial; 2005; 21():188-93. PubMed ID: 16686316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum osteoprotegerin levels are increased in patients with advanced prostate cancer.
    Brown JM; Vessella RL; Kostenuik PJ; Dunstan CR; Lange PH; Corey E
    Clin Cancer Res; 2001 Oct; 7(10):2977-83. PubMed ID: 11595685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.